Saturday 17 October 2026
Export BGM’s income statement to Excel — free account
BGM Group Ltd.
BGM Healthcare Drug Manufacturers Specialty & Generic
BGM Group Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $37.9 million, up 51.1% from fiscal 2024.
8.65
0.06
+0.70%
Follow BGM
| Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 5 | 4 | 6 | 4 | 6 | 3 |
P/E ratio |
21.28 | 21.28 | 21.28 | 21.28 | 1,487.50 | 1,487.50 | 1,967.50 | 3,995.00 | 5,120.00 |
Altman Z-Score |
— | — | — | — | 134.16 | 81.91 | 75.66 | 117.66 | 498.01 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | 4.23 | 6.23 | 5.67 | 5.97 | 9.16 | 10.34 | 7.99 | 9.65 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | (2.37) | (1.61) | 0.23 | (3.52) | (0.79) | (2.89) | (0.93) |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.12) | (0.18) | (0.15) | (0.08) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.32) | (0.32) | (0.32) | (0.32) | (0.23) | (0.55) | (1.31) | (5.95) | 3.97 |
EV/FCF |
(0.32) | (0.32) | (0.32) | (0.32) | (0.32) | (0.86) | (2.33) | 6.15 | 1.02 |
Quick Ratio |
0.38 | 0.49 | 0.45 | 0.70 | 0.79 | 1.72 | 3.66 | 2.24 | 0.36 |
Current Ratio |
1.22 | 1.55 | 2.14 | 2.04 | 2.22 | 3.27 | 5.18 | 3.39 | 1.24 |
Net Debt/EBITDA |
0.45 | (0.27) | 0.04 | (0.76) | (1.28) | (4.46) | 14.96 | (26.94) | 0.97 |
Debt/Assets |
0.00% | 10.92% | 13.90% | 15.27% | 10.51% | 0.22% | 0.94% | 0.00% | 0.00% |
Debt/Equity |
0.62 | 0.21 | 0.22 | 0.25 | 0.14 | 0.00 | 0.01 | 0.00 | 0.00 |
Asset Turnover |
0.68 | 3.02 | 1.34 | 1.20 | 0.92 | 0.93 | 0.80 | 0.48 | 0.16 |
Operating CF/Net income |
1.90 | 0.86 | (0.11) | 1.00 | 0.11 | 11.75 | (0.04) | (0.38) | 0.12 |
Capex/Depreciation |
0.00 | (0.89) | (0.52) | (0.39) | (2.76) | (2.66) | (3.25) | (3.18) | (1.49) |
Interest Coverage |
8.00 | 27.62 | 27.62 | 19.81 | 41.39 | (84.42) | 26.31 | (0.88) | 151.40 |
| 10.65% | 35.70% | 26.42% | 19.67% | 7.37% | 1.93% | (15.67%) | (3.26%) | (9.15%) | |
| 4.24% | 31.01% | 15.54% | 12.14% | 5.11% | 1.54% | (13.44%) | (2.77%) | (8.19%) | |
ROIC |
0.00% | 23.72% | 16.83% | 12.36% | 2.87% | 3.27% | (7.28%) | (1.36%) | (2.06%) |
Return on Tangible Assets |
11.03% | 31.58% | 25.42% | 19.10% | 10.07% | 3.61% | (21.03%) | (4.87%) | (96.46%) |
Average Days of Receivables |
16.33 | 9.62 | 4.78 | 8.16 | 11.08 | 4.59 | 15.52 | 22.44 | 40.94 |
Research and Development Expense of Revenue |
0.37% | 0.34% | 0.10% | 0.11% | 0.01% | 1.89% | 0.00% | 5.42% | 1.77% |
Selling, General and Administrative Expense of Revenue |
9.62% | 4.29% | 7.60% | 5.45% | 5.69% | 6.36% | 9.39% | 13.22% | 48.05% |
Intangible Assets out of Total Assets |
0.00 | 0.06 | 0.05 | 0.04 | 0.03 | 0.03 | 0.07 | 0.09 | 0.82 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 26.98% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
4.70% | 4.70% | 4.70% | 4.70% | 0.07% | 0.07% | 0.05% | 0.03% | 0.02% |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.63 | 8.39 | 7.68 | 8.34 | 8.38 | 9.07 | 6.43 | 3.47 | 0.33 |
Operating CF per Share |
0.08 | 0.74 | (0.10) | 0.85 | 0.05 | 1.77 | 0.04 | 0.08 | (0.02) |
Capex per Share |
0.00 | (0.19) | (0.10) | (0.08) | (0.51) | (0.46) | (0.51) | (0.54) | (0.02) |
Free Cash Flow per Share |
0.08 | 0.55 | (0.20) | 0.77 | (0.46) | 1.31 | (0.47) | (0.47) | (0.04) |
Cash per Share |
0.16 | 0.94 | 0.77 | 1.98 | 1.85 | 2.10 | 3.10 | 2.51 | 0.10 |
Shareholders Equity per Share |
0.31 | 2.95 | 3.77 | 4.81 | 8.31 | 7.69 | 6.14 | 6.10 | 3.46 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.31 | 2.95 | 3.77 | 4.81 | 8.31 | 7.69 | 6.14 | 6.10 | 3.46 |
Free Cash Flow |
2.68 | 3.32 | (1.20) | 4.62 | (3.15) | 9.40 | (3.40) | (3.39) | (4.56) |
Working Capital |
3.99 | 7.88 | 13.31 | 19.09 | 22.19 | 20.85 | 27.85 | 20.99 | 9.95 |
Capital Expenditures |
(1.53) | (1.12) | (0.62) | (0.46) | (3.49) | (3.26) | (3.71) | (3.93) | (2.19) |
Net Current Asset Value |
2.23 | 6.55 | 12.34 | 18.22 | 21.68 | 20.47 | 27.61 | 20.86 | 9.63 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.02 | 0.01 | 0.01 | 0.06 | 0.05 | 0.08 | 0.16 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.14 | 0.15 | 0.16 | 0.16 | 0.14 | 0.14 | 0.13 | 0.14 | 0.14 |
Cash ROIC |
11.15% | 12.31% | (3.73%) | 9.61% | (4.08%) | 13.41% | (5.06%) | (5.44%) | (1.13%) |
Accounts Receivable Turnover |
7.70 | 43.13 | 47.74 | 58.10 | 40.04 | 50.89 | 33.30 | 14.26 | 13.08 |
Accounts Payable Turnover |
4.54 | 10.00 | 9.94 | 10.69 | 8.96 | 9.46 | 10.07 | 5.44 | 5.92 |
Inventory Turnover |
1.48 | 3.49 | 3.29 | 3.47 | 4.20 | 5.49 | 6.45 | 4.18 | 2.51 |
Average Days of Payables |
89.29 | 32.50 | 35.78 | 37.60 | 50.43 | 32.93 | 29.32 | 71.76 | 75.70 |
Days of Inventory on Hand |
278.94 | 82.84 | 125.52 | 103.03 | 88.63 | 55.28 | 40.74 | 87.84 | 232.15 |
Average Receivables |
2.93 | 1.17 | 0.97 | 0.86 | 1.43 | 1.27 | 1.40 | 1.76 | 2.90 |
Average Payables |
4.22 | 4.22 | 3.67 | 3.97 | 5.74 | 6.20 | 4.44 | 3.86 | 5.34 |
Average Inventory |
12.94 | 12.11 | 11.05 | 12.26 | 12.25 | 10.69 | 6.94 | 5.02 | 12.58 |
Average Assets |
33.36 | 16.67 | 34.30 | 41.71 | 61.75 | 69.94 | 57.89 | 52.13 | 243.41 |
Average Common Equity |
13.28 | 14.48 | 20.18 | 25.74 | 42.76 | 55.82 | 49.66 | 44.22 | 218.00 |
Columns are period end dates